LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00053
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)

2012English

Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice

ISRN Pain
2014English

Antidepressant-Like Effects of LPM580153, a Novel Potent Triple Reuptake Inhibitor

Scientific Reports
Multidisciplinary
2016English

Treatment of Temporomandibular Pain With the Selective Serotonin Reuptake Inhibitor Paroxetine

The Primary Care Companion to The Journal of Clinical Psychiatry
2007English

Treatment With the Selective Serotonin Reuptake Inhibitor, Fluoxetine, Attenuates the Fish Hypoxia Response

Scientific Reports
Multidisciplinary
2016English

Evaluation of the Analgesic Effects of Ammoxetine, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor

Acta Pharmacologica Sinica
MedicinePharmacology
2016English

Drug Interaction of Fluvoxamine, a Selective Serotonin Reuptake Inhibitor

Folia Pharmacologica Japonica
Pharmacology
2006English

Selective Noradrenaline Reuptake Inhibitor Atomoxetine Directly Blocks hERG Currents

British Journal of Pharmacology
Pharmacology
2009English

Sibutramine, a Serotonin–norepinephrine Reuptake Inhibitor, Causes Fibrosis in Rats

Environmental Toxicology and Pharmacology
MutagenesisToxicologyHealthPharmacologyMedicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy